Health care stocks were flat to lower premarket Thursday as the Health Care Select Sector SPDR Fund (XLV) was down 0.4% and the iShares Biotechnology ETF (IBB) was recently inactive.
BrightSpring Health Services (BTSG) shares advanced by 5% after the company reported higher Q4 adjusted earnings and revenue. The company also raised its 2025 revenue outlook.
Aquestive Therapeutics (AQST) shares were down nearly 7% after the company reported a wider Q4 net loss as revenue fell during the period.
QIAGEN (QGEN) shares were up nearly 2% after the company said the US Food and Drug Administration has cleared the QIAstat-Dx Gastrointestinal Panel 2 Mini B for clinical use, marking the company's second FDA clearance of a QIAstat-Dx panel in 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.